Name: Nuvation Bio Inc. (NUVB) Financial Statements
Creator: FinSpry

Nuvation Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Nuvation Bio Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	7.87	0.00	0.00	0.00	0.00
Cost of Revenue	7.08	0.00	0.00	0.00	0.00
Gross Profit	0.80	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	524.19	71.29	87.82	69.04	32.60
Selling, General & Administrative	69.23	29.48	31.92	24.28	11.22
Operating Expenses	593.42	99.82	119.73	93.32	43.55
Operating Income	-592.63	-99.82	-119.73	-93.32	-43.55
Other Income/Expense
Interest Income	27.06	24.61	7.45	2.96	1.95
Interest Expense	0.34	0.00	0.00	0.00	0.00
Other Income/Expense	-2.03	-0.59	8.09	3.51	-0.22
Income
Income Before Tax	-567.94	-75.80	-104.20	-86.85	-41.66
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-567.94	-75.80	-104.20	-86.85	-41.66
Net Income - Continuous Operations	-567.94	-75.80	-104.20	-86.85	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-566.92	-99.60	-119.54	-93.13	-43.45
EBIT	-567.60	-99.82	-119.73	-93.32	-43.55
Depreciation & Amortization	0.68	0.20	0.20	0.18	0.10
Earnings Per Share
Basic EPS	-2.00	-	-	-	-
Diluted EPS	-2.00	-	-	-	-
Basic Shares Outstanding	268.77	0.22	216.72	197.89	97.53
Diluted Shares Outstanding	268.77	0.22	216.72	197.89	97.53